His main research concerns Pathology, Glioma, Surgery, Astrocytoma and Radiation therapy. He frequently studies issues relating to Oligodendroglioma and Pathology. His Oligodendroglioma research incorporates elements of Grading and Proportional hazards model.
His study in Angiocentric Glioma and Anaplastic astrocytoma is done as part of Glioma. His work focuses on many connections between Astrocytoma and other disciplines, such as Internal medicine, that overlap with his field of interest in Gastroenterology. Within one scientific family, Peter C. Burger focuses on topics pertaining to Magnetic resonance imaging under Radiation therapy, and may sometimes address concerns connected to Third ventricle.
His primary scientific interests are in Pathology, Glioma, Surgery, Internal medicine and Oncology. The study incorporates disciplines such as Astrocytoma, Oligodendroglioma and Central nervous system disease in addition to Pathology. Specifically, his work in Glioma is concerned with the study of Anaplastic astrocytoma.
His study in Radiation therapy, Chemotherapy, El Niño, Progressive disease and Retrospective cohort study falls under the purview of Surgery. His Chemotherapy study integrates concerns from other disciplines, such as Toxicity and Ependymoma. His Internal medicine study combines topics in areas such as Gastroenterology and Medulloblastoma.
Peter C. Burger focuses on Internal medicine, Oncology, Pathology, Glioma and Medulloblastoma. The Internal medicine study which covers Surgery that intersects with Spinal Cord Neoplasm, Pathological, Medical diagnosis and Anaplastic astrocytoma. His work in the fields of Oncology, such as Chemoradiotherapy, overlaps with other areas such as Isotretinoin.
His Pathology research is multidisciplinary, incorporating elements of Fusion gene, Oligodendroglioma and IDH1. The various areas that he examines in his Glioma study include Antibody, Survival analysis and Adjuvant therapy. His work in Radiation therapy addresses subjects such as Chemotherapy, which are connected to disciplines such as Ependymoma.
Peter C. Burger mainly investigates Pathology, Internal medicine, Glioma, Oncology and Cancer research. His Pathology research is multidisciplinary, relying on both Young adult, Fusion gene and IDH1. His Internal medicine study incorporates themes from Gastroenterology and Medulloblastoma.
His Glioma study combines topics from a wide range of disciplines, such as Gene rearrangement, Survival analysis, MYB, Epigenetics and Adjuvant therapy. His Oncology research is multidisciplinary, relying on both Oncogenic mutation, Clinical course, Carboplatin, Anaplastic astrocytoma and Pineoblastoma. His research in Radiation therapy intersects with topics in Brain tumor, Epidemiology, Chemotherapy and Ependymoma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The 2007 WHO Classification of Tumours of the Central Nervous System
David Neil Louis;Hiroko Ohgaki;Otmar D. Wiestler;Webster K. Cavenee.
Acta Neuropathologica (2007)
The WHO Classification of Tumors of the Nervous System
Paul Kleihues;David N. Louis;Bernd W. Scheithauer;Lucy B. Rorke.
Journal of Neuropathology and Experimental Neurology (2002)
5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers.
Adrian Merlo;James G. Herman;Li Mao;Daniel J. Lee.
Nature Medicine (1995)
Histological Typing of Tumours of the Central Nervous System
P. Kleihues;Peter C. Burger;Bernd W. Scheithauer;K. J. Zülch.
Definitions and Explanatory Notes
P. Kleihues;P. C. Burger;B. W. Scheithauer.
The new WHO classification of brain tumours.
Paul Kleihues;Peter C. Burger;Bernd W. Scheithauer.
Brain Pathology (1993)
Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas
H Brem;S Piantadosi;S Piantadosi;P.C Burger;M Walker.
The Lancet (1995)
Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia
Manel Esteller;Stanley R. Hamilton;Peter C. Burger;Stephen B. Baylin.
Cancer Research (1999)
The Molecular Basis of Turcot's Syndrome
Stanley R. Hamilton;bo Liu;Ramon E. Parsons;Nickolas Papadopoulos.
The New England Journal of Medicine (1995)
Tumors of the Central Nervous System
Peter C. Burger;Bernd W. Scheithauer.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: